Create Free Account

By creating account you will get access to hot stocks & personalised emails

CogState Ltd

Healthcare AU CGS

1.37AUD
-0.03(2.14%)

Last update at 2024-05-02T06:10:00Z

Day Range

1.351.38
LowHigh

52 Week Range

1.121.87
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 3.03M 10.69M 5.82M -2.07918M -3.85072M
Minority interest - - - - -
Net income 3.57M 7.52M 5.23M -1.31580M -2.49577M
Selling general administrative 14.41M 11.80M 10.26M 8.43M 13.70M
Selling and marketing expenses 0.07M 0.04M 0.11M 0.16M 0.25M
Gross profit 21.59M 26.68M 17.94M 10.40M 10.16M
Reconciled depreciation 2.59M 2.32M 2.30M 2.93M 0.71M
Ebit 3.09M 10.78M 5.91M -1.92657M -3.76672M
Ebitda 5.69M 13.11M 8.21M 0.08M -3.27128M
Depreciation and amortization 2.59M 2.32M 2.30M 2.01M 0.50M
Non operating income net other - - - - -
Operating income 3.44M 15.85M 5.12M -4.09817M -3.76672M
Other operating expenses 2.33M 4.55M 4.83M 2.24M 27.69M
Interest expense 0.07M 0.09M 0.09M 0.15M 0.08M
Tax provision -0.54262M 3.17M 0.59M -0.76338M -1.35495M
Interest income 0.70M 0.05M 0.01M 0.02M 0.03M
Net interest income 0.63M -0.03519M -0.07912M -0.22237M -0.09187M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.54262M 3.17M 0.59M -0.76338M -1.35495M
Total revenue 40.45M 44.98M 32.69M 23.69M 21.83M
Total operating expenses 19.34M 15.82M 14.11M 12.32M 16.01M
Cost of revenue 18.86M 18.30M 14.75M 13.29M 11.68M
Total other income expense net 0.14M -0.13249M 2.07M -0.01309M -0.08400M
Discontinued operations - - - - -
Net income from continuing ops 3.57M 7.52M 5.23M -1.91723M -3.55877M
Net income applicable to common shares 3.57M 7.52M 5.23M -1.31580M -2.49577M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 54.07M 58.45M 51.38M 31.64M 19.24M
Intangible assets 11.11M 10.77M 8.72M 6.95M 4.94M
Earning assets - - - - -
Other current assets 1.22M 2.08M 1.81M 0.78M 0.78M
Total liab 16.38M 25.52M 29.60M 15.52M 9.13M
Total stockholder equity 37.69M 32.92M 21.78M 16.13M 10.11M
Deferred long term liab - - - - -
Other current liab 6.74M 12.03M 9.40M 17.39M 5.58M
Common stock 36.32M 36.15M 34.03M 33.04M 25.34M
Capital stock 36.32M 36.15M 34.03M 33.04M 25.34M
Retained earnings -0.16249M -3.25281M -10.80276M -15.60525M -14.18072M
Other liab - 6.67M 9.53M 0.64M 0.34M
Good will - - - - -
Other assets 3.58M 3.66M 5.80M 4.98M 3.69M
Cash 28.68M 30.60M 23.64M 10.33M 3.22M
Cash and equivalents 20.19M 18.19M 10.01M 10.33M 1.06M
Total current liabilities 12.17M 18.26M 18.93M 13.14M 8.79M
Current deferred revenue 5.01M 4.64M 7.13M -8.79613M 2.07M
Net debt -28.41300M -29.36877M -21.90038M -5.27847M -2.71104M
Short term debt 0.24M 0.64M 0.61M 3.31M 0.50M
Short long term debt 0.12M 0.18M - 3.69M 0.72M
Short long term debt total 0.26M 1.23M 1.74M 5.05M 0.50M
Other stockholder equity -54.28422M -47.64193M -30.97105M -24.33188M -2.94480M
Property plant equipment 0.60M 2.02M 2.79M 3.61M 1.34M
Total current assets 38.78M 42.00M 34.07M 16.11M 9.27M
Long term investments - - - - -
Net tangible assets - 22.16M 13.06M 9.18M 5.17M
Short term investments - - - - -
Net receivables 7.63M 8.32M 7.88M 4.35M 5.44M
Long term debt - - - - -
Inventory 1.25M 1.01M 0.74M 0.64M -0.16910M
Accounts payable 0.19M 0.95M 1.79M 1.24M 0.63M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1.53M 0.03M -1.44031M -1.30446M -1.04846M
Additional paid in capital - - - - -
Common stock total equity - - - 48.14M 36.14M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -17.58047M -18.51540M -15.35466M -15.30219M 0.00000M
Deferred long term asset charges - - - - -
Non current assets total 15.28M 16.45M 17.31M 15.54M 9.97M
Capital lease obligations 0.26M 1.23M 1.74M 3.67M -
Long term debt total 0.03M 0.59M 1.13M 1.74M 0.00000M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -1.68043M -3.53011M -2.62081M -4.12103M -3.38990M
Change to liabilities 0.00000M -2.13498M 14.36M -0.22823M -0.38006M
Total cashflows from investing activities -1.68043M -3.53011M -2.62081M -2.82827M -1.94395M
Net borrowings - -0.64791M -0.79155M 1.65M 1.65M
Total cash from financing activities -0.89488M 0.76M -0.18358M 9.21M 0.85M
Change to operating activities - -0.63959M -0.53962M 0.54M 0.01M
Net income 5.36M 10.89M 6.98M -2.83509M -3.56366M
Change in cash -1.92118M 6.96M 13.31M 7.11M -1.15029M
Begin period cash flow 30.60M 23.64M 10.33M 3.22M 4.37M
End period cash flow 28.68M 30.60M 23.64M 10.33M 3.22M
Total cash from operating activities 0.98M 14.09M 21.49M 1.06M -0.06102M
Issuance of capital stock 0.18M 1.41M 0.61M 7.69M 0.85M
Depreciation 1.30M 1.78M 1.92M 2.01M 0.71M
Other cashflows from investing activities 0.53M 0.03M 0.64M 0.31M 0.50M
Dividends paid - 1.08M - 3.23M 1.71M
Change to inventory - - - - -
Change to account receivables 0.82M -0.32742M -4.76275M -0.00622M 2.06M
Sale purchase of stock -0.57052M -0.57052M 0.61M -0.13262M -0.13262M
Other cashflows from financing activities -0.50872M -3.53011M -2.62081M 5.68M 2.63M
Change to netincome 1.06M 2.32M -1.95025M -0.25247M 0.01M
Capital expenditures 2.21M 3.56M 3.26M 3.14M 2.44M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.82M -0.32742M -4.76275M -0.00622M 0.27M
Stock based compensation 2.38M 3.20M 0.61M -0.17050M -
Other non cash items -5.67138M 1.41M 12.59M 1.89M 2.86M
Free cash flow -1.22835M 10.53M 18.23M -2.07843M -2.44004M

Fundamentals

  • Previous Close 1.40
  • Market Cap234.84M
  • Volume81746
  • P/E Ratio27.40
  • Dividend Yield-%
  • EBITDA4.55M
  • Revenue TTM41.08M
  • Revenue Per Share TTM0.22
  • Gross Profit TTM 20.65M
  • Diluted EPS TTM0.05

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CGS
CogState Ltd		 -0.03 2.14% 1.37 27.40 32.79 5.22 3.67 4.24 22.21
PME
Pro Medicus Ltd		 2.85 2.61% 112.10 167.31 113.64 78.98 70.50 78.09 106.71
VHT
Volpara Health Technologies Ltd		 -0.005 0.44% 1.14 - - 7.65 6.53 7.78 -60.9831
ONE
Oneview Healthcare PLC		 -0.015 5.45% 0.26 - - 26.22 16.80 25.10 -29.9289
M7T
Mach7 Technologies Ltd		 -0.01 1.41% 0.70 - - 6.26 3.10 8.57 -10.6285

Reports Covered

Stock Research & News

View All

Profile

Cogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research. Its cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. The company is also involved in the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its technology and associated services are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The company also provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2023, it had participated in approximately 1,800 academic research studies and 530 industry sponsored clinical trials. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.

CogState Ltd

367 Collins Street, Melbourne, VIC, Australia, 3000

Key Executives

Name Title Year Born
Mr. Bradley John O'Connor B.Bus, C.A., CA CEO, MD & Exec. Director NA
Prof. Paul Maruff BBSc (Hons), Ph.D. Founder & Chief Innovation Officer NA
Mr. Darren Watson Chief Financial Officer NA
Mr. Benjamin Bloomfield Chief Technology Officer NA
Mr. Kenneth Billard Chief Commercial Officer NA
Dr. Chris Edgar Ph.D. Chief Science Officer NA
Ms. Rachel Colite VP of Strategic Initiatives, Communication & People NA
Mr. David James Franks B.Ec, BEc, C.A., CA, F Fin, J.P., JP. Company Sec. 1970
Dr. Amy E. Veroff Ph.D. Principal Consultant NA
Mr. Bradley John O'Connor B.Bus, C.A., CA CEO, MD & Executive Director NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.